Medtronic Inc. (Minneapolis) and Biosense Webster Inc. (Diamond Bar, CA), a Johnson & Johnson company, recently announced a strategic alliance designed to advance the care of patients with cardiac ...

Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc.

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology ...

Jim Harbaugh told reporters Tuesday he had two successful surgeries during the 2025 NFL offseason. One was a hip replacement; the other was a cardiac ablation done after the 61-year-old coach ...

Researchers at RIT are developing non-invasive technology that will better assess cardiac tissue response to thermal energy, a common therapy approach for both cancer and cardiac arrhythmia treatments ...

HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) ...